Browse > Article
http://dx.doi.org/10.22537/jksct.16.2.165

Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy for Treatment of Calcium Channel Blockers, Angiotensin II Receptor Blockers, and Metformin Overdose  

Jeong, Jae Han (Department of Thoracic and Cardiovascular Surgery, Chosun University College of Medicine)
Sun, Kyung Hoon (Department of Emergency Medicine, Chosun University College of Medicine)
Park, Yong Jin (Department of Emergency Medicine, Chosun University College of Medicine)
Kim, Sun Pyo (Department of Emergency Medicine, Chosun University College of Medicine)
Publication Information
Journal of The Korean Society of Clinical Toxicology / v.16, no.2, 2018 , pp. 165-171 More about this Journal
Abstract
An overdose of antihypertensive agents, such calcium channel blockers (CCBs) and angiotensin II receptor blocker (ARBs), and the antihyperglycemic agent, metformin, leads to hypotension and lactic acidosis, respectively. A 40-year-old hypertensive and diabetic man with hyperlipidemia and a weight of 110 kg presented to the emergency room with vomiting, dizziness, and hypotension following an attempted drug overdose suicide with combined CCBs, ARBs, 3-hydroxy-3-methylglutaryl-coemzyme A reductase inhibitors, and metformins. A conventional medical treatment initially administered proved ineffective. The treatment was then changed to simultaneous extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), which was effective. This shows that simultaneous ECMO and CRRT can be an effective treatment protocol in cases of ineffective conventional medical therapy for hypotension and lactic acidosis due to an overdose of antihypertensive agents and metformin, respectively.
Keywords
Calcium channel blockers; Angiotensin receptor antagonist; Metformin; Extracorporeal membrane oxygenation; Renal replacement therapy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Vignesh C, Kumar M, Venkataraman R, Rajagopal S, Ramakrishnan N, Abraham BK. Extracorporeal membrane oxygenation in drug overdose: A clinical case series. Indian J Crit Care Med 2018;22:111-5.   DOI
2 Weinberg RL, Bouchard NC, Abrams DC, Bacchetta M, Dzierba AL, Brodie D. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion 2014;29:53-6.   DOI
3 Vincent JL, Castanares Zapatero D. The role of hypotension in the development of acute renal failure. Nephrol Dial Transplant 2009;24:337-8.
4 Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999;341:1447-57.   DOI
5 St-Onge M, Anseeuw K, Cantrell FL, Gilchrist IC, Hantson P, Bailey B, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med 2017;45:e306-15.   DOI
6 Tsoi B, Akioyamen LE, Bonner A, Frankfurter C, Levine M, Pullenayegum E, et al. Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung Circ 2018;27:666-82.   DOI
7 James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al.2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.   DOI
8 Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994;30:187-228.   DOI
9 Eisenberg MJ, Brox A, Bestawros AN. Calcium channel blockers: an update. Am J Med 2004;116:35-43.   DOI
10 Bologa C, Lionte C, Coman A, Sorodoc L. Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose-case report. Am J Emerg Med 2013;31:1154.
11 Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Eng J Med 2001;344:1721-2.   DOI
12 Bailey CJ, Turner RC. Metformin. N Engl J Med 1996:334:574-9.   DOI
13 Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009;37:2191-6.   DOI
14 Keller G, Cour M, Hernu R, Illinger J, Robert D, Argaud L. Management of metformin-associated lactic acidosis by continuous renal replacement therapy. Plos One 2011;6:e23200.   DOI
15 DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metforminassociated lactic acidosis: Current perspectives on causes and risk. Metabolism 2016;65:20-9.   DOI
16 Vecchio S, Giampreti A, Petrolini VM, Lonati D, Protti A, Para P, et al. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila) 2014;52:129-35.   DOI
17 Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 1992;105:1009-13.   DOI
18 Calello DP, Liu KD, Wiegand TJ, Roberts DM, Lavergne V, Gosselin S, et al. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med 2015;43:1716-30.   DOI
19 Macedo E, Mehta RL. Continuous dialysis therapies: Core curriculum 2016. Am J Kidney Dis 2016;68:645-57.   DOI
20 Laine K, Kivisto KT, Laakso I, Neuvonen PJ. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol 1997;43:29-33.   DOI
21 Tintinalli JE, Stapczynski JS, Ma OJ, Yealy DM, Meckler GD, Cline DM. Emergency medicine: A comprehensive study guide. 8th ed. New York:McGraw-Hill;2016.p.1294-5.
22 Raeble MA. Hyperkalemia associated with use of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther 2012;30:e156-66.   DOI
23 Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care 2018;22:52.   DOI
24 Celotto AC, Capellini VK, Baldo CF, Dalio MB, Rodrigues AJ, Evora PR. Effects of acid-base imbalance on vascular reactivity. Braz J Med Biol Res 2008;41:439-45.   DOI